Datawatch: Deeper Value For A Lower Price [View article]
Agreed... very good point on Tableau. It should pull through some additional sales for Datawatch. The ECM angle should also be very beneficial. I bought when I actually used one of their programs at an SAP shop a couple of years ago and was really impressed. I would have thought it would have been bought by now. Would appreciate your thoughts in that regard.
March Import/Export Prices: Import prices -0.5% vs. consensus of -0.5% and -0.6% prior. Export prices were -0.4% vs. consensus of -0.1% and +0.7% prior (revised). [View news story]
Banks and lobbyists got a look at the latest Fed minutes yesterday afternoon according to a list which shows the 150 e-mail addresses that received the release Tuesday. Among the big banks whose officials got the message: JPMorgan, Goldman Sachs, Nomura, and Citigroup.[View news story]
Nothing to see here folks, move along, move along... I wonder how much it cost the bankers to get that little tidbit from their congressional minions? Or maybe they did it on contingency?
A Real Dividend Growth Machine: Q1 2013 Review [View article]
Outstanding job! 15 years from now you will be very, very pleased with your disciplined approach. One piece of advice, if you decide to marry, get a prenup to protect your hard work. ;-)
Why Value Investors Are Going To Cash [View article]
Agree with Derek - there's very little quality that can be bought cheap right now... even high yield is crummy.... perhaps that we're long cash, and short of good opportunities is a signal of a top...
on the flipside, we are de facto fighting the Fed here and all the other central banks on a debasing race to the bottom.... :-)
Stock futures slide, but are off the lows following news of Cyprus' proposal for a one-time tax on bank deposits as part of a Troika bailout. Dow -0.5%, S&P -0.8%, Nasdaq -0.95%. [View news story]
Stock futures slide, but are off the lows following news of Cyprus' proposal for a one-time tax on bank deposits as part of a Troika bailout. Dow -0.5%, S&P -0.8%, Nasdaq -0.95%. [View news story]
Just when I think about, here comes zerohedge with my answer...
Stock futures slide, but are off the lows following news of Cyprus' proposal for a one-time tax on bank deposits as part of a Troika bailout. Dow -0.5%, S&P -0.8%, Nasdaq -0.95%. [View news story]
Best line I heard today on it: "Well I guess you don't prevent a bank run...by STARTING one." LOL.
I wonder if deposit (and IRA/401k) taxation will be coming to the US sometime soon....
War Dividends: Buy Lockheed Martin And General Dynamics On The Recent Pullback [View article]
I was just about to ask the same question PalmDesert raises. NOC is a winner. SAIC, CAI, etc. etc. the complex will do fine, just watch the housing markets in Northern Virginia and Maryland.
Novo Nordisk (NVO) shares plunge 11.85% premarket after the FDA unexpectedly rejected the company's Tresiba long-acting insulin and a related product called Ryzodeg. The FDA requested more data from a dedicated cardiovascular outcomes trial, which Novo doesn't expect to be able to provide this year. Tresiba and Ryzodeg are approved in Europe and Japan, and are forecast to generate billions of dollars of sales - assuming U.S. approval. [View news story]
Agreed with jrobins. This is not really an outright rejection, it is a delay/request for additional information, for which Novo management was clearly not prepared. it's a good opportunity to add.
Attractively Valued Blue-Chip Dividend Champions For Your Retirement Portfolios [View article]
Great stuff optionsmaven. Is there a broker/dealer with the cost model that makes this feasible? Is this a sharebuilder.com portfolio or is this more for a thinkorswim type account or other? (no affiliation with either mentioned.)
Attractively Valued Blue-Chip Dividend Champions For Your Retirement Portfolios [View article]
I am in agreement with kwm3. This is precisely what I have been looking for as far as a strategy for income portfolios. Thanks very much. Between fastgraphs, chuck and your ideas, SA has been incredibly valuable.
Datawatch: Deeper Value For A Lower Price [View article]
I bought when I actually used one of their programs at an SAP shop a couple of years ago and was really impressed. I would have thought it would have been bought by now. Would appreciate your thoughts in that regard.
March Import/Export Prices: Import prices -0.5% vs. consensus of -0.5% and -0.6% prior. Export prices were -0.4% vs. consensus of -0.1% and +0.7% prior (revised). [View news story]
Banks and lobbyists got a look at the latest Fed minutes yesterday afternoon according to a list which shows the 150 e-mail addresses that received the release Tuesday. Among the big banks whose officials got the message: JPMorgan, Goldman Sachs, Nomura, and Citigroup. [View news story]
Winner Takes All: The Super-Priority Status Of Derivatives [View article]
These Companies Are Minting Debt To Buy Back Stock [View article]
A Real Dividend Growth Machine: Q1 2013 Review [View article]
Why Value Investors Are Going To Cash [View article]
on the flipside, we are de facto fighting the Fed here and all the other central banks on a debasing race to the bottom.... :-)
14.5% Dividend Payer KKR Quadrupled Its Economic Net Income In 2012 - More Growth Ahead [View article]
Stock futures slide, but are off the lows following news of Cyprus' proposal for a one-time tax on bank deposits as part of a Troika bailout. Dow -0.5%, S&P -0.8%, Nasdaq -0.95%. [View news story]
http://bit.ly/XnGk5E
Stock futures slide, but are off the lows following news of Cyprus' proposal for a one-time tax on bank deposits as part of a Troika bailout. Dow -0.5%, S&P -0.8%, Nasdaq -0.95%. [View news story]
http://bit.ly/WTsPQj
Stock futures slide, but are off the lows following news of Cyprus' proposal for a one-time tax on bank deposits as part of a Troika bailout. Dow -0.5%, S&P -0.8%, Nasdaq -0.95%. [View news story]
I wonder if deposit (and IRA/401k) taxation will be coming to the US sometime soon....
War Dividends: Buy Lockheed Martin And General Dynamics On The Recent Pullback [View article]
Novo Nordisk (NVO) shares plunge 11.85% premarket after the FDA unexpectedly rejected the company's Tresiba long-acting insulin and a related product called Ryzodeg. The FDA requested more data from a dedicated cardiovascular outcomes trial, which Novo doesn't expect to be able to provide this year. Tresiba and Ryzodeg are approved in Europe and Japan, and are forecast to generate billions of dollars of sales - assuming U.S. approval.
[View news story]
Attractively Valued Blue-Chip Dividend Champions For Your Retirement Portfolios [View article]
Attractively Valued Blue-Chip Dividend Champions For Your Retirement Portfolios [View article]